Can the concept of hormesis be generalized to carcinogenesis?

Regulatory Toxicology and Pharmacology

Volumn 28, Issue 3, 1998, Pages 230-241

  Calabrese, Edward J ^a   Baldwin, Linda A ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGEN;

CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; DATA BASE; DOSE RESPONSE; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT;

ANIMALIA;

EID: 0032450381     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.1998.1267     Document Type: Article

References (38)

1. BELLE Newslett., 1995, Dose-response studies of genotoxic rodent carcinogens: Thresholds, hockey sticks, hormesis or straight lines, 3, 1, 19.
2. Broerse J. J., Knaan S., van Bekkum D. W., Hollander C. F., Noteboom A. L., van Zwieten M. J. Mammary carcinogenesis in rats after X- and neutron irradiation and hormone administration. Late Biol. Effects Ionizing Radiat. II:1978;13-27.
3. Broerse, J. J. Hennen, L. A. van Zwieten, M. J. Hollander, C. F. 1982, Mammary carcinogenesis in different rat strains after single and fractionated irradiations. Commission of the European Communities Report, 155, 168.
4. Broerse J. J., Hennen L. A., Klapwijk W. M., Solleveld H. A. Mammary carcinogenesis in different rat strains after irradiation and hormone administration. Int. J. Radiat. Biol. 51:1987;1091-1100.
5. Calabrese E. J., Baldwin L. A. The dose determines the stimulation (and poison): Development of a chemical hormesis database. Int. J. Toxicol. 16:1997a;545-559.
6. Calabrese E. J., Baldwin L. A. A quantitatively-based methodology for the evaluation of chemical hormesis. Hum. Ecol. Risk Assess. 3:1997b;545-554.
7. Camurri L., Codeluppi S., Scarduelli L., Candela S. Sister chromatid exchange in workers exposed to low doses of styrene. Sister Chromatid Exchanges, Part B. 1983;Plenum Press, New York. p. 957-963.
8. Chandra R. K. 1990 McCollum award lecture: Nutrition and immunity - Lessons from the past and new insights into the future. Am. J. Clin. Nutr. 53:1991;1087-1101.
9. Conolly R. B., Andersen M. E. Hepatic foci in rats after diethylnitrosamine initiation and 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 146:1997;281-293.
10. Cook R. R. Responses in humans to low level exposures. Calabrese E. J. Biological Effects of Low Level Exposures: Dose-Response Relationships. 1994;99-109 Lewis Publishers, Boca Raton.
11. Downs T. D., Frankowski R. F. Influence of repair processes on dose-response models. Drug Metab. Rev. 13:1982;839-852.
12. Fan F., Wierda D., Rozman K. K. Effects of 2,3,7,8-tetrachlorodibenzo-p. Toxicology. 106:1996;221-228.
13. Germolec D. R., Spalding J., Boorman G. A., Wilmer J. L., Yoshida T., Simeonova P. P., Bruccoleri A., Kayama F., Gaido K., Tennant R., Burleson F., Dong W., Lange R. W., Luster M. I. Arsenic can mediate skin neoplasia by chronic stimulation of keratinocyte-derived growth factors. Mutat. Res. 386:1997;209-218.
14. Germolec D. R., Yoshida T., Gaido K., Wilmer J. L., Simeonova P. P., Kayama F., Tennant R., Burleson F., Dong W., Lange R. W., Luster M. I. Arsenic induces overexpression of growth factors in human keratinocytes. Toxicol. Appl. Pharmacol. 141:1996;308-318.
15. Goldsworthy T., Campbell H. A., Pitot H. C. The natural history and dose-response characteristics of enzyme-altered foci in rat liver following phenobarbital and diethylnitrosamine administration. Carcinogenesis. 5:1984;67-71.
16. Hagiwara H., Hirose M., Takahashi S., Ogawa K., Shirai T., Ito N. Forestomach and kidney carcinogenicity of caffeic acid in F344 rats and C57BL/6N × C3H/HeN F1 mice. Cancer Res. 51:1991;5655-5560.
17. Hanham A. F., Dunn B. P., Stich H. F. Clastogenic activity of caffeic acid and its relationship to hydrogen peroxide generated during autooxidation. Mutat. Res. 116:1983;333-339.
18. Hirose M., Kawabe M., Shibata M., Takahashi S., Okazaki S., Ito N. Influence of caffeic acid and otheroNNN. Carcinogenesis. 13:1992;1825-1828.
19. Hirose M., Masuda A., Fukushima S., Ito N. Effects of subsequent antioxidant treatment on 7,12-dimethylbenz(a. Carcinogenesis. 9:1988;101-104.
20. Hirose M., Mutai M., Takahashi S., Yamada M., Fukushima S., Ito N. Effects of phenolic antioxidants in low dose combination on forestomach carcinogenesis in rats pretreated withNNN. Cancer Res. 51:1991;824-827.
21. IARC Monogr. 56:1993;114-134.
22. Kitchin K. T., Brown J. L. Dose-response relationship for rat liver DNA damage caused by 49 rodent carcinogens. Toxicology. 88:1994;31-49.
23. Kitchin K. T., Brown J. L. Response to: Dose-response studies of genotoxic rodent carcinogens: Thresholds, hockey sticks, hormesis or straight lines. BELLE Newslett. 3:1995;16-19.
24. Kitchin K. T., Brown J. L. Dose-response relationship for rat liver DNA damage caused by 1,2-dimethylhydrazine. Toxicology. 114:1996;113-124.
25. Kleczkowska H. E., Althaus F. R. Response of human keratinocytes to extremely low concentrations ofNNN. Mutat. Res. 367:1996;151-159.
26. Kociba R. J., Keyes D. G., Beyer J. E., Carreon R. M., Wade C. E., Ditenber D. A., Kalnins R. P., Frauson L. E., Park C. N., Barnard S. D., Hummel R. A., Humiston C. G. Results of a 2-year chronic toxicity and oncogenicity study of 2,3,7,8-tetrachlorodibenzo-p. Toxicol. Appl. Pharmacol. 46:1978;279-303.
27. 6in vitro. Carcinogenesis. 18:1997;1889-1895.
28. Lutz U., Lugli S., Bitsch A., Schlatter J., Lutz W. K. Dose response for the stimulation of cell division by caffeic acid in forestomach and kidney of the male F344 rat. Fundam. Appl. Toxicol. 39:1997;131-137.
29. Nesnow S., Ross J., Nelson G., Wilson K., Roop B., Jeffers A., Galati A., Stoner G., Sangaiah R., Gold A. Cyclopenta[c,dras. Carcinogenesis. 15:1994;601-606.
30. O'Gara R. W., Kelly M. G., Brown J., Mantel N. Induction of tumors in mice given a minute single dose of dibenz[a,h. J. Natl. Cancer Inst. 35:1965;1027-1042.
31. Office of Technology Assessment (OTA), 1977, Cancer Testing Technology and Saccharin, U.S. Government Printing Office, Washington, DC.
32. Pitot H. C., Goldsworthy T. L., Moran S., Kennan W., Glauert H. P., Maronpot R. R., Campbell H. A. A method to quantitate the relative initiating and promoting potencies of hepatocarcinogenic agents in their dose-response relationships to altered hepatic foci. Carcinogenesis. 8:1987;1491-1499.
33. Prahalad A. K., Ross J. A., Nelson G. B., Roop B. C., King L. C., Nesnow S., Mass M. J. Dibenzo[a,lras. Carcinogenesis. 18:1997;1955-1963.
34. Stebbing A. R. D. A theory for growth hormesis. BELLE Newslett. 6:1997;1-11.
35. Tanaka T., Kojima T., Kawamori T., Wang A., Suzui M., Okamoto K., Mori H. Inhibition of 4-nitroquinoline-1-oxide-induced rat and tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids. Carcinogenesis. 14:1993;1321-1325.
36. Teeguarden J. G., Dragan Y. P., Singh J., Vaughan J., Goldsworthy T. L., Pitot H. C. Time and dose dependence of altered hepatic foci by 2,3,7,8-tetrachlorodibenzo-p. Toxicologist. 30:1996;163.
37. Waalkes M. P., Rham S., Riggs C. W., Bare R. M., Devor D. E., Poirier L. A., Wenk M. L., Henneman J. R., Balaschak M. S. Cadmium carcinogenesis in male Wistar [Crl:(WI)BR] rats: Dose-response analysis of tumor induction in the prostate and testes and at the injection site. Cancer Res. 48:1988;4656-4663.
38. Wattenberg L. W., Coccia J. B., Lam L. K. T. Inhibitory effects of phenolic compounds on benzo(a. Cancer Res. 40:1980;2820-2823.